COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 55 of 872 for:    LENALIDOMIDE AND cells

Combination Chemotherapy and Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02561273
Recruitment Status : Active, not recruiting
First Posted : September 28, 2015
Last Update Posted : September 10, 2019
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Matthew Lunning, DO, University of Nebraska

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 2020
Estimated Study Completion Date : October 2021